Previous Article | Next Article ![]()
Journal of Virology, June 2000, p. 5712-5715, Vol. 74, No. 12
Virus des Hépatites, Rétrovirus
Humains et Pathologies Associées, INSERM U271, 69 424 Lyon Cedex
03, France
Received 6 July 1999/Accepted 29 February 2000
A human lymphoid cell line (F172-D8) excreting a human
immunodeficiency virus type 1 (HIV-1) anti-gp41 monoclonal antibody was
used to construct a plasmid containing the cDNA of the single-chain variable fragment (scFvD8) corresponding to this antibody. A stable human osteosarcoma cell line was obtained which expressed the scFvD8
protein in the cytoplasm. Whereas a cell line transfected with a
control construct (pCI-neo) was readily and productively infected with
laboratory (Ba-L) or primary HIV-1 isolates, the scFvD8 cell line did
not support productive infection. Binding of the virus,
internalization, and reverse transcription were not altered by scFvD8
expression, but gp160 expression was dramatically reduced. These data
suggest that cytoplasmic expression of this artificial single-chain
antibody can interfere with gp160 expression, thereby reducing the
production of mature viral envelope proteins.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Design and Intracellular Activity of a Human Single-Chain
Antibody to Human Immunodeficiency Virus Type 1 Conserved gp41
Epitope
and
*
Corresponding author. Mailing address: U342 INSERM,
ICGM, Hôpital St Vincent de Paul, 82 ave. Denfert-Rochereau,
75014 Paris, France. Phone: (33) 1-43-20-89-74. Fax: (33)
1-40-48-83-52. E-mail: desgranges{at}cochin.inserm.fr.
Present address: Pasteur Mérieux Connaught France, Marcy
l'Etoile, France.
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|